2022 Annual Meeting | IS1 - Invited Science: Epilepsy
Program Materials Program Evaluations
| 01:00 PM - 01:15 PM PDT | Speaker |
Metabolic flexibility underlies the ability of 2DG to attenuate hyperexcitability following traumatic brain injury
Sadi Quinones |
| 01:00 PM - 01:00 PM PDT | Speaker |
walk in slides
Sadi Quinones |
| 01:15 PM - 01:20 PM PDT | Q&A |
Questions and Answers
Sadi Quinones |
| 01:20 PM - 01:35 PM PDT | Speaker |
Common Risk Variants for Epilepsy are Enriched in Families Previously Targeted for Rare “Monogenic” Variant Discovery
Colin A. Ellis, MD |
| 01:35 PM - 01:40 PM PDT | Q&A |
Questions and Answers
Colin A. Ellis, MD |
| 01:40 PM - 01:55 PM PDT | Speaker |
An Expanded Genotype-phenotype Analysis of 11,500 People with Epilepsy
David J. Lewis-Smith, MD |
| 01:55 PM - 02:00 PM PDT | Q&A |
Questions and Answers
David J. Lewis-Smith, MD |
| 02:00 PM - 02:15 PM PDT | Speaker |
Genetic Diagnosis in Pediatric Epilepsy Impacts Medical Management
Isabel Haviland, MD |
| 02:15 PM - 02:20 PM PDT | Q&A |
Questions and Answers
Isabel Haviland, MD |
| 02:20 PM - 02:35 PM PDT | Speaker |
Laser Interstitial Thermal Therapy for Mesial Temporal Lobe Epilepsy: Multicenter Study in 268 Consecutively Treated Patients Including Outcomes of Subsequent Temporal Lobectomy for Seizure Recurrence
Brett Youngerman, MD, MS |
| 02:35 PM - 02:40 PM PDT | Q&A |
Questions and Answers
Brett Youngerman, MD, MS |
| 02:40 PM - 02:55 PM PDT | Speaker |
Brain Aging in Childhood-Onset Epilepsy: A Prospective Population-Based Study
Bruce Hermann, PhD |
| 02:55 PM - 03:00 PM PDT | Q&A |
Questions and Answers
Bruce Hermann, PhD |
| Sadi Quinones | Sadi Quinones has nothing to disclose. |
| Colin A. Ellis, MD | Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. |
| Isabel Haviland, MD | Isabel Haviland, MD has nothing to disclose. |
| Bruce Hermann, PhD | Bruce Hermann, PhD has nothing to disclose. |
| Brett Youngerman, MD, MS | Brett Youngerman, MD, MS has nothing to disclose. |
| Lindsey Morgan, MD | The institution of Dr. Morgan has received research support from NIH. The institution of Dr. Morgan has received research support from PERF. |
| Amy R. Brooks-Kayal, MD, FAAN | Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brooks-Kayal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Brooks-Kayal has stock in Johnson and Johnson. The institution of Dr. Brooks-Kayal has received research support from NINDS. |
| David J. Lewis-Smith, MD | The institution of Dr. Lewis-Smith has received research support from Wellcome Trust. Dr. Lewis-Smith has received personal compensation in the range of $500-$4,999 for serving as a Young Investigator Award with American Epilepsy Society. |